University of Kansas Cancer Center Post San Antonio Review
Playback speed
10 seconds
What's New in HER2+ MBC Targeted Therapy: Efficacy Analysis of Oral HER2-TKIs Tucatinib & Neratinib
380 views
March 5, 2021
Comments 0
Login to view comments.
Click here to Login
2021